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Abstract Although smoking-related diseases, such as
chronic obstructive pulmonary disease (COPD), are often
accompanied by increased peripheral muscle fatigability,
the extent to which this is a feature of the disease or a direct
eVect of smoking per se is not known. Skeletal muscle
function was investigated in terms of maximal voluntary
isometric torque, activation, contractile properties and fati-
gability, using electrically evoked contractions of the quad-
riceps muscle of 40 smokers [19 men and 21 women; mean
(SD) cigarette pack years: 9.9 (10.7)] and age- and physical
activity level matched non-smokers (22 men and 23
women). Maximal strength and isometric contractile speed
did not diVer signiWcantly between smokers and non-smok-
ers. Muscle fatigue (measured as torque decline during a
series of repetitive contractions) was greater in smokers
(P = 0.014), but did not correlate with cigarette pack years
(r = 0.094, P = 0.615), cigarettes smoked per day (r = 10.092,
P = 0.628), respiratory function (%FEV1pred) (r = ¡0.187,
P = 0.416), or physical activity level (r = ¡0.029,
P = 0.877). While muscle mass and contractile properties
are similar in smokers and non-smokers, smokers do suVer
from greater peripheral muscle fatigue. The observation
that the cigarette smoking history did not correlate with
fatigability suggests that the eVect is either acute and/or
reaches a ceiling, rather than being cumulative. An acute
and reversible eVect of smoking could be caused by carbon
monoxide and/or other substances in smoke hampering
oxygen delivery and mitochondrial function.
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Introduction
Smoking is a recognized risk factor for many chronic dis-
eases, such as chronic obstructive pulmonary disease
(COPD). Patients with COPD often complain of exercise
intolerance and fatigue, which can be attributed to deterio-
ration in lung function and systemic eVects such as muscle
atrophy and a slow-to-fast transition in Wbre type composi-
tion (Wüst and Degens 2007). However, also otherwise
non-symptomatic smokers often complain of an increased
sensation of whole body fatigability (Corwin et al. 2002).
The aetiology of this earlier onset of whole body fatigue in
smokers is unknown and it is unclear as to whether smok-
ing itself contributes to this phenomenon or other factors
such as a decreased level of physical activity (Larsson and
Orlander 1984; Larsson et al. 1988; Orlander et al. 1979).
Recently we reported that in young male smokers, matched
for physical activity with control subjects, smoking itself
causes a signiWcant decline in skeletal muscle fatigue
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resistance (Morse et al. 2007). The decline in Wtness during
prolonged smoking (Bernaards et al. 2003) suggests, how-
ever, that long-term smoking may also cause a progressive
deterioration of skeletal muscle fatigue resistance.
We hypothesized that the reduction in skeletal muscle
function and fatigue resistance would be related to the
cumulative dose of smoking. Consequently we have exam-
ined the muscle fatigability of subjects with a range of
exposures to smoking. To assess the eVects of smoking
duration on muscle function we have used electrically
evoked contractions of the quadriceps muscle of otherwise
healthy smokers. Electrical stimulation avoids possible
motivational bias and also allows determination of contrac-
tile properties such as the torque–frequency relationship
and the rate of relaxation. The intermittent fatigue protocol
used in this study mimics, to some extent, the rhythmic
muscle contractions involved in activities of daily life such
as cycling, walking and stair negotiation.
Methods and materials
Participants
Males and females were analysed separately, because of
sex diVerences in fatigability (Wüst et al. 2008, in press),
smoking reportedly only aVecting the experience of fatigue
in men (Corwin et al. 2002) and diVerences between sexes
in vulnerability to COPD (Gan et al. 2006). Eighty-Wve
people volunteered for the study after giving written
informed consent. All procedures were approved by the
Local Ethics Committee and were in accordance with the
Helsinki Declaration.
The smokers and non-smokers were matched for age and
physical activity. Physical activity was assessed by ques-
tionnaire (Baecke et al. 1982). Low values (<7) represent a
low physical activity level. Exclusion criteria were known
respiratory, cardiovascular or neuromuscular diseases and
leg injuries. Participants were asked to refrain from smok-
ing and caVeine intake two hours prior to testing. The force
expiratory volume in 1-s [FEV1 (L)], predicted FEV1 (%
FEV1pred), forced vital capacity (FVC) and %FEV1/FVC
were determined with standard spirometry (Vitalograph,
Buckingham, England).
Measurement of anatomical cross-sectional area
Anatomical cross-sectional area (ACSA) of the quadriceps
muscle at 50% of femur length was measured with magnetic
resonance imaging (MRI) using a Wxed 0.2-T MRI scanner
(E-Scan, ESAOTE Biomedica, Genova, Italy). Scans were
obtained with a T1 weighted, high resolution, gradient echo
proWle, with the following scanning parameters: time to
echo—16 ms; repetition time—100 ms; Weld of view—
330 mm £ 254 mm—matrix: 256 £ 256, and a slice thick-
ness of 5 mm. Participants were supine for 15 min prior to
the scan to make sure any Xuid shifts had stabilized.
Measurement of maximal isometric voluntary 
knee extension strength
Participants were familiarized with the testing procedures
on a separate day prior to data collection. All knee exten-
sion torque measurements were performed on the right leg
with a Cybex norm dynamometer (Ronkonkoma, New
York, USA) with the hip joint at 90° Xexion. Participants
undertook a standardized warm-up before the measure-
ments and were given visual feedback and verbal encour-
agement during the isometric maximal voluntary
contractions (MVCs) at knee joint angles of 60, 70 and 80°
(full extension = 0°). The angle at which the highest torque
was achieved was deWned as the optimal joint angle at
which all subsequent measurements were made. Torque
signals were sampled at 2,000 Hz and Wltered with a low-
pass fourth-order Butterworth Wlter with a 30-Hz cut-oV
frequency. OV-line analysis was performed using Matlab
(the Mathwork Inc., S. Natik, MA, USA).
Voluntary activation
Beside muscle wasting, loss of strength can also be caused
by a diminished ability to maximally activate the muscle.
This ability was determined using the interpolated twitch
technique (Shield and Zhou 2004). Doublet pulses (pulse
width 50 s, 100 Hz; DSV Digitimer Stimulator, Digitimer
Ltd, Herts, UK) were applied percutaneously using stimula-
tion pads (Versastim, Conmed Corp., NY, USA) with the
anode placed proximally and the cathode distally over the
quadriceps muscle. The current required for supra-maximal
stimulation was assessed by administering single pulses at
rest. The ratio of electrically evoked torque superimposed
on an MVC to the force of a pre-contraction doublet pro-
vided an index of voluntary activation (VA). After the VA
was determined the stimulation current was set at a level to
produce approximately 30% of MVC torque when stimulat-
ing at 100 Hz and this current was used throughout the rest
of the experiment.
Torque–frequency relationship and contractile speed
The torque–frequency relationship and maximal rate of
relaxation (MRR) both give an indication of the contractile
speed and Wbre type composition of the muscle (Scott et al.
2006). The torque–frequency relationship of the quadriceps
muscle was assessed by stimulating in random order at 1,
10, 15, 20, 30, 50 and 100 Hz for 1 s, each separated byEur J Appl Physiol (2008) 104:103–110 105
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1m i n .  D i Verences in the torque–frequency curves were
assessed using the 10 Hz/100 Hz ratio (FF10/FF100). The
MRR was determined from the 50-Hz contraction (MRR50)
as peak dF/dt normalized to the maximal torque generated
during that contraction.
Fatigue test
Five minutes after determining the torque–frequency rela-
tion, fatigue resistance was assessed by stimulating the
quadriceps muscle with 30-Hz trains for 2 min (1 s on 1 s
oV). Torque and MRR for each contraction were expressed
as a percentage of the Wrst contraction. The percentage
torque remaining after 2 min was deWned as the fatigue
index. The coeYcient of variation between days was 2.3
and 5.3% for the torque–frequency relationship and fatigue
test, respectively (n = 3 non-smokers).
Statistical analysis
DiVerences between groups were tested using a 2 £ 2
ANOVA with factors: smoke (non-smokers and smokers)
and sex, with age as a covariant. The correlations between
smoking habits and fatigability were performed using a par-
tial correlation, correcting for age and gender. DiVerences
were considered signiWcant when P < 0.05. Results are pre-
sented as mean (SEM) unless otherwise stated.
Results
Subject characteristics
Table 1 shows the anthropometric characteristics of the par-
ticipants. Age, physical activity levels, body mass, body
mass index and lung function (FEV1, FVC or %FEV1/FVC)
were similar in smokers and non-smokers, although
%FEV1pred tended to be signiWcantly lower in smokers
(P = 0.092). Although we did not check whether the airXow
limitation in three smokers with an FEV1/FVC < 70% was
reversible, this value suggests that they might have (undi-
agnosed) mild to moderate COPD (GOLD stage I or II).
The inclusion of their data, however, did not alter the
results of the present study.
Muscle strength, size and voluntary activation level
The VA was higher in the smokers (Table 2). Maximal
torque capacity (MVC corrected for VA; MTC) was lower
in women than men (Table 2) and decreased in both men
and women during ageing (Fig. 1). If we consider smoking
or non-smoking there was no diVerence in MTC and ACSA
(Table 2). However, stepwise linear regression showed that
height, age, gender, physical activity level and years
smoked signiWcantly predict the ACSA (R2 = 0.793;
P < 0.001), while cigarette pack years and cigarettes
smoked per day did not improve the model.
Contractile properties
No diVerences were observed in the torque–frequency rela-
tionship or MRR50 between smokers and non-smokers
(Table 2). Women however, had, on average, slower con-
tractile properties than men as reXected by the less negative
MRR50 and the higher FF10/FF100 (Table 2).
Fatigue
Figure 2a and b show a typical example of the fatigue test
(Fig. 2a), and an example of the reduction in torque and
rate of relaxation from the Wrst to the last contraction
(Fig. 2b). In all groups there was a progressive decline in
Table 1 Subjects characteristics
Values are displayed as mean § SD (range)
No diVerences were observed between smokers and non-smokers, ** P < 0.005 from men. FVC forced vital capacity, FEV1 forced expiratory vol-
ume in 1 s in L or as a percentage of predicted
Male non-smokers Male smokers Female non-smokers Female smokers
n 22 19 23 21
Age (years) 38.1 § 17.8 (21–73) 37.0 § 18.4 (18–72) 42.4 § 20.4 (19–72) 37.5 § 17.4 (18–66)
Body mass (kg) 77 § 9 (63–95) 77 § 12 (62–99) 66 § 3 (53–83)** 74 § 12 (56–96)**
BMI (kg m¡1)2 4 § 2 (22–29) 24 § 3 (18–30) 24 § 3 (19–29) 27 § 4 (22–34)
FVC (L) 5.4 § 1.0 (3.6–7.3) 5.1 § 1.3 (3.6–7.2) 3.6 § 0.7 (2.5–4.8)** 3.7 § 0.8 2.4–5.3)**
FEV1 (L) 4.3 § 1.0 (2.8–6.1) 4.0 § 0.9 (2.6–5.6) 3.0 § 0.6 (2.0–3.9)** 2.9 § 0.8 (1.5–4.2)**
%FEV1pred 99.3 § 13.2 (78.7–125.5) 91.0 § 11.5 (81.0–111.8) 101.2 § 14.7 (76.4–127.8) 92.0 § 19.5 (47.6–119.9)
FEV1/FVC (%) 78.7 § 6.6 (60.2–91.6) 78.0  § 9.4 (66.4–93.4) 81.7 § 4.8 (71.9–88.6) 77.9 § 10.5 (51.7–93.0)
Physical activity level 8.2 § 1.4 (6.0–10.8) 8.3 § 1.4 (5.6–12.0) 8.1 § 1.2 (5.8–9.5) 8.1 § 1.4 (5.8–10.5)106 Eur J Appl Physiol (2008) 104:103–110
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torque (Fig. 3) and MRR, the latter indicating a slowing of
the muscle (Fig. 4). Women were more fatigue resistant
than men (P < 0.001), both in terms of torque and MRR. In
both men and women, the fatigue resistance was lower in
smokers than non-smokers (P = 0.014) (Fig. 3). The
absence of a smoke £ sex interaction indicates that the
eVect of smoking was similar in both sexes.
The fatigue index in smokers was not related to cigarette
pack years (Fig. 5), packs smoked per day (r = ¡0.092,
P = 0.628), physical activity level (r = ¡0.029, P =0 . 8 7 7 ) ,
age (r = 0.101,  P = 0.557) or lung function in terms of
%FEV1pred ( r = ¡0.187,  P = 0.416) or %FEV1/FVC
(r = 0.03,  P = 0.824). Also, there was no relationship
between lung function (FEV1pred) and fatigue index
(r = ¡0.027, P = 0.921) when controlling for cigarette pack
years, the number of smoking years and number of ciga-
rettes smoked per day. Similar results were obtained for the
decline in MRR. Stepwise linear regression revealed that
gender (P = 0.015) and being a smoker or non-smoker
(P = 0.024) explained 19.2% of the variance between the
participants.
Discussion
We observed that smoking, in the absence of overt lung dis-
ease, is not accompanied by muscle weakness and wasting
or changes in contractile properties of the quadriceps mus-
cle after taking into account age, sex and physical activity.
Despite an absence in changes in contractile properties and
muscle weakness, the muscles of smokers were, however,
more fatigable. This eVect was similar in men and women.
Previously we have shown that young smoking men show
greater fatigability (Morse et al. 2007) and here we hypoth-
esized that the eVect would increase with increasing smok-
ing volume. The absence of correlations between muscle
Table 2 Values for muscle strength, size and contractile properties [mean (SEM)]
VA voluntary activation, MVC maximal voluntary contraction, MTC maximal torque capacity (maximal voluntary contraction corrected for VA),
ACSA anatomical cross-sectional area; FF10/FF100 force frequency relationship: torque produced at 10 Hz relative to 100 Hz, MRR50 maximal rate
of relaxation at 50 Hz
9 P < 0.05 from non-smokers; * P < 0.05 from men; ** P < 0.005 from men
Male non-smokers Male smokers Female non-smokers Female smokers
VA (%) 85.9 (3.0) 92.0 (2.3)9 88.1 (2.2) 90.0 (3.3)9
MVC (Nm) 286 (21) 280 (18) 190 (12)** 204 (15)**
MTC (Nm) 330 (18) 300 (19) 213 (12)** 219 (15)**
ACSA (cm2) 72 (2) 65 (3) 53 (2) 52 (2)
FF10/FF100 31.3 (1.4) 31.4 (3.0) 33.3 (1.5)* 38.0 (2.0)*
MRR50 (s¡1) ¡15.1 (0.3) ¡16.0 (0.7) ¡12.7 (0.4)** ¡12.9 (0.8)**
Fig. 1 Maximal torque capac-
ity, maximal voluntary torque 
corrected for voluntary activa-
tion (MTC) of the quadriceps 
muscle expressed as a function 
of age in male (a) and female (b) 
smokers and non-smokers. The 
decrease in maximal strength 
over time (and smoke exposure) 
was similar between smokers 
and non-smokers (NS)
Fig. 2 Representative example of a fatigue test (a), with in b the Wrst
(continuous line) and last (dotted line) contraction enlargedEur J Appl Physiol (2008) 104:103–110 107
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fatigability and any measure of smoking volume contra-
dicts this hypothesis and suggests that the eVect of smoking
on skeletal muscle fatigability is of an acute nature and/or
reaches a ceiling where an increased daily smoking volume
does not aggravate the eVect.
Maximal strength, size and voluntary activation
We did not Wnd a lower maximal voluntary torque in smok-
ers, despite a slightly higher VA level. The higher VA
might be due to an increase in sympathetic nerve activity in
smokers (Narkiewicz et al. 1998), possibly due to a central
stimulant action of nicotine (Mundel and Jones 2006). Yet,
this eVect is insigniWcant as the maximal capacity of the
muscle to generate torque (maximal torque corrected for
VA) was also similar between smokers and non-smokers.
Others (Al-Obaidi et al. 2004; Orlander et al. 1979), how-
ever, did report a lower maximal strength in smokers than
non-smokers, but smokers and non-smokers were not
matched for physical activity level, a factor very likely to
aVect maximal voluntary force. Other factors that may con-
tribute to muscle weakness via muscle wasting are systemic
inXammation and oxidative stress (Wüst and Degens 2007;
Gan et al. 2005). The observation that the amount of years
smoked predicted the ACSA of the quadriceps muscle sug-
gests that long term smoking produces a small degree of
muscle wasting. Surprisingly, we did not observe similar
diVerences in the maximal strength of the quadriceps.
Contractile properties
The torque–frequency relationship did not diVer between
smokers and non-smokers, suggesting that no signiWcant, if
any, shift in Wbre type composition had occurred with
Fig. 5 Relationship between cigarette pack years and fatigue resis-
tance of the quadriceps muscle for male (Wlled circle) and female (open
square) smokers of the fatigue test. Fatigue index was calculated as
torque at the end of the test as a percentage of the initial value. The cor-
relation coeYcient was 0.095 (P = 0.618) for fatigue index and similar
results were obtained from other measures of smoking history (see
text)
Fig. 3 Torque, expressed as 
percentage of initial value, dur-
ing the fatigue protocol is plotted 
every 2 s during the fatigue pro-
tocol for male (a) and female (b) 
smokers and non-smokers. 
Women had a signiWcantly high-
er fatigue resistance (P < 0.001). 
Both male and female smokers 
fatigued more than the non-
smokers (P =0 . 0 1 4 )
Fig. 4 Maximal rates of relaxa-
tion (MRR), expressed as per-
centage of initial value, during 
the fatigue protocol are plotted 
every 2 s during the stimulation 
for male (a) and female (b) 
smokers and non-smokers. Sig-
niWcantly higher values were ob-
tained in the females compared 
to the males (P < 0.001). MRR 
decreased to a signiWcantly low-
er level in the smokers compared 
to the non-smokers (P =0 . 0 0 8 )108 Eur J Appl Physiol (2008) 104:103–110
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smoking. Moreover, the MRR, a broad measure of muscle
speed and Wbre type composition (Hamada et al. 2003) was
not diVerent between smokers and non-smokers. In line
with our observation, it has been found that diVerent doses
of cigarette smoke did not lead to changes in Wbre type dis-
tribution in the rat (Nakatani et al. 2003). Orlander et al.
(1979), however, found a lower percentage type I Wbres in
smokers, but this may be related to diVerences in physical
activity level which was not controlled in their study.
Peripheral muscle fatigability
The main Wnding of the present study is a lower skeletal
muscle fatigue resistance in smokers. Interestingly, the
reduction in fatigue resistance was similar in men and
women and, contrary to our hypothesis, was not related to
several measures of smoking history. The increased fatiga-
bility could be caused by neuromuscular transmission fail-
ure, shift to a more fatigable Wbre type, reduction in oxygen
supply to the muscle and/or the oxidative capacity of the
muscle (Degens and Veerkamp 1994).
The likelihood of electrical failure either at the neuro-
muscular junction or T-tubules was minimized by keeping
the stimulation frequency relatively low and allowing suY-
cient recovery intervals (Jones 1996). Therefore, the site of
fatigue is most likely distal to the neuromuscular junction
(Bigland-Ritchie et al. 1982).
Another factor possibly aVecting muscle fatigue is the
Wbre type distribution of the muscle since type II Wbres
have a higher ATP turnover for the same isometric tension
than type I Wbres (Stienen et al. 1996). Also, they generally
have a lower oxidative capacity and fatigue more rapidly
(Degens and Veerkamp 1994). However, we did not
observe any diVerences in MRR or torque–frequency rela-
tionship, both an in vivo suggestion of a diVerent Wbre type
composition. It is thus unlikely that this explains the higher
fatigability in smokers.
Another factor inXuencing muscle fatigue is the oxida-
tive capacity of the muscle. Earlier studies have found that
smokers have a lower activity of mitochondrial enzymes,
such as cytochrome oxidase (Larsson and Orlander 1984;
Orlander et al. 1979). The present study does not allow us
to Wrm conclusions regarding oxidative capacity.
Impaired oxygen transport to skeletal muscle
The absence of a signiWcant correlation between cigarette
pack years and fatigability of the muscle and no indication
for changes in Wbre type composition that could explain the
reduced fatigue resistance in smokers suggest that smoking
acutely hampers the oxygen and/or energy delivery. An
impaired oxygen delivery may occur if the blood Xow is
diminished or the oxygen content of the blood is lower than
normal. Exercise-induced vasodilatation has been reported
to be lower in smokers than physical activity matched non-
smokers (Gaenzer et al. 2001), which may be due to an
impaired nitric oxide generation (Montes de Oca et al.
2008) and/or an increased oxidative stress (Gaenzer et al.
2001; Tsuchiya et al. 2002).
A diminished oxygen delivery can also result from a
reduced oxygen content of the blood. In smokers this could
arise when the oxygen binding sites on haemoglobin (Hb)
become occupied with carbon monoxide (CO), resulting in
hypoxemia. Indeed, carboxyhaemoglobin (COHb) may
reach levels of 9% in smokers (Rietbrock et al. 1992). Yet,
we showed previously that subjects were no more fatigable
in acute hypoxia when using the same protocol (Degens
et al. 2006). It therefore seems unlikely that hypoxemia is
the factor that distinguishes the smokers from the non-
smokers. The eVect of CO via its action on Hb can, how-
ever, not completely be excluded as, in contrast to hypox-
emia, the oxygen dissociation curve exhibits a shift to the
left, inhibiting the release of oxygen from Hb (Rietbrock
et al.  1992). Indeed, inhalation of CO acutely impaired
maximal oxygen consumption in both healthy participants
(Aronow and Cassidy 1975; Klausen et al. 1983; Seppanen
1977) and patients with COPD (Aronow et al. 1977). More-
over, experimentally elevating blood COHb to 6% resulted
in an increased fatigability in a test identical to our fatigue
protocol (Morse et al. 2008). Combined with the data in the
present study this suggests that smoking may have an acute
and reversible eVect on skeletal muscle fatigability caused
by CO in cigarette smoke. This then would result in a
lower, but reversible, fatigue resistance in smokers.
Besides the eVect of CO on oxygen supply to the tissue,
CO might also bind to Mb, limiting intra-cellular facilitated
diVusion of oxygen. Also, CO blocks complex IV of the
mitochondrial respiratory chain causing an overall decline
in mitochondrial function (Alonso et al. 2003). Cardellach
et al. (2003) showed that mitochondrial respiratory chain
function [complex III and IV (cytochrome oxidase)] in
lymphocytes was decreased in smokers, but returned to nor-
mal values after smoking cessation. It should be noted,
however, that not only CO, but also tar (Pryor et al. 1992)
and cyanide (Nelson 2006) in the cigarette smoke could
directly reduce mitochondrial respiratory chain function.
That the eVects of smoking on skeletal muscle fatigability
may be acute and reversible is further supported by the sim-
ilar fatigue resistance—using the same fatigue test as in the
present study—in non-smoking patients with COPD
(Degens et al. 2005).
In conclusion, skeletal muscle from smokers is more
fatigable than that of age- and physical activity-matched
non-smokers, while contractile properties of the skeletal
muscle were not diVerent. The decrease in fatigue resis-
tance was similar in men and women and not related toEur J Appl Physiol (2008) 104:103–110 109
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smoking history. This suggests that smoking itself acutely
aVects skeletal muscle fatigue resistance. We speculate
that this may occur via an acute and potentially reversible
smoking-induced oxygen delivery to the working muscle
and/or impairment of the function of Hb and myoglobin
due to CO. Moreover, CO and other factors in smoke
inhibit enzymes in the respiratory chain (such as cyto-
chrome oxidase). If smoking indeed has an acute eVect on
muscle fatigue resistance, smoking cessation may be
helpful in the management of the exercise intolerance and
sensations of fatigue in smokers, whether or not they
suVer from clinical symptoms of chronic diseases such as
COPD or heart failure. It may also help to break the
vicious circle of disuse in order to prevent sensations of
fatigue that in turn will cause a further decrease in physi-
cal Wtness.
Open Access This article is distributed under the terms of the Crea-
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